Immunotherapy activates your immune system to kill bladder cancer cells. Trimodal therapy (TMT) removes the bladder tumor followed by chemotherapy and radiation treatments. TMT combines surgery ...

She had subsequently undergone successful, simultaneous surgeries for resection of a basal cell carcinoma of the nasal skin and lymphoma of the bladder. Investigations Physical examination ...

A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study ...

"Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...

as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The trial met its primary endpoint of event-free survival (EFS ...

LAS VEGAS -- Patients with high-risk, treatment-unresponsive non-muscle invasive bladder cancer (NMIBC) had an unprecedented response rate and disease-free survival (DFS) with an investigational ...

Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor. Cell and gene therapy, which offer many advantages in treating BLCA, are urgently ...

1 However, sales for Ferring’s new bladder cancer treatment Adstiladrin were ... to establish Adstiladrin as the new standard of care and backbone therapy across the urothelial cancer disease spectrum ...

“PIN1 is a master cancer ... of cancer therapy. “What I found most interesting about this work is the combination of two mechanisms that promote tumor progression,” he said. “It’s opening the gates ...

More than 12,300 people were diagnosed with bladder cancer in Canada in 2024. In the latest edition of Health Matters, Sarah Ryan shows us some of the signs and symptoms to watch for, and explains how ...